✦ LIBER ✦

Cost-Effectiveness of Bendamustine Versus Fludarabine for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Colombia

✍ Scribed by Bertwistle, D.; Munakata, J.; Wehler, E; Leyva, V.; Ariza, J.G.; Zambrano, C.; Gonzalez, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Cost-Effectiveness of Bendamustine V

✍ Bertwistle, D.; Munakata, J.; Wehler, E.; Leyva, V.; Valencia, A.; Hernandez, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Cost/Benefit Analysis of First Line Chro

✍ Wehler, E.; Leyva, V.; Bertwistle, D.; Munakata, J.; Valencia, A.; Hernandez, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PCN90 Cost Effectiveness Analysis of Ben

✍ S. Vandekerckhove; K. Holtzer-Goor; D. Van Den Steen; Y. van Megen; P. Huijgens; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Fludarabine plus cyclophosphamide versus

✍ Eichhorst, B. F. 📂 Article 📅 2005 🏛 American Society of Hematology 🌐 English ⚖ 242 KB

Cost-effectiveness of adding rituximab t

✍ Hornberger, John; Reyes, Carolina; Shewade, Ashwini; Lerner, Susan; Friedmann, M 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 369 KB

PCN60 Cost Effectiveness of Nilotinib, D

✍ Romero Martin, R.M.; Alvis Nelson, A.N.; De los Ríos Magalí, D.L.R.M.; Chávez Di 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB